Impact report – Financial statements 2022
The financial statements to accompany Lung Foundation Australia’s Annual Report of 2022.
Submission to the Australian Cancer Plan Consultation
The Australian Cancer Plan, the first national cancer plan for Australia, will set priorities for reform for the next decade. The Plan is coordinated by…
NSPS Scientific and Evidence Report – Silicosis in Australia
Silicosis is an entirety preventable, fibrotic occupational respiratory disease, which is specifically caused by inhalational exposure to silica dust. In recent years, there has been…
Transforming the agenda for COPD
Our new Blueprint report, Transforming the agenda for COPD: A path towards prevention and lifelong lung health, provides the government with five urgent actions to…
The Next Breath: Accelerating Lung Cancer Reform in Australia
The Blueprint, The Next Breath: Accelerating Lung Cancer Reform in Australia, identifies the critical issues in lung cancer that need government investment and coordinated national…
COVID-19: A roadmap for recovery
The following report COVID-19: A roadmap for recovery by Lung Foundation Australia discusses the results from our national survey about the experiences of Australians throughout the COVID-19…
National Dust Disease Taskforce Consultation Synthesis
The National Dust Disease Taskforce (NDDT) Consultation Synthesis provides a high-level synthesis of the insights, views, feedback and advice gathered by the National Dust Disease…
Impact report – Financial statements 2021
The financial statements to accompany Lung Foundation Australia’s Annual Report of 2020/2021.
Impact Report 2020/2021
Lung Foundation Australia’s 2020/2021 Annual Report featuring the organisation’s key highlights.
Submission to the National Medicines Policy Consultation
Click here for Lung Foundation Australia’s response to the National Medicines Policy Consultation in 2021.